Topic orientation
Fluoxymesterone at a glance
The strongest research directions include Pharmacology and Side effects. Use the connected concepts below as starting points, not as a keyword checklist.
Research this topic
Explore the main themes, entities and connections around Fluoxymesterone. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Explore this topic
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
Pharmacology
Side effects
Society and culture
Overview
Key facts & relationships
High-confidence facts extracted from structured source data. Use them as anchors for further research.
- 3D model (JSmol)
- Interactive image
- AHFS/Drugs.com
- Monograph
- ATC code
- G03BA01 (WHO)
- Bioavailability
- Oral: 80%
- CAS Number
- 76-43-7 Y
- ChEBI
- CHEBI:5120 Y
Topics to explore
A structured outline of related entities, concepts and subtopics. Open any item to build a new map centered on it.Browse the full topic structure. Each item opens a new analysis centered on that subject.
Overview
- Androgenic Androgen
- Anabolic steroid
- Low testosterone levels Hypogonadism
- Delayed puberty
- Breast cancer
- Anemia
- By mouth Oral administration
- Side effects Side effect
- Symptoms Symptom
- Masculinization Virilization
- Acne
- Increased hair growth Hirsutism
- Voice changes Voice deepening
- Sexual desire Libido
- Liver damage Hepatotoxicity
- Cardiovascular
- Hypertension
- Synthetic Synthetic compound
- Agonist
- Androgen receptor
- Biological target
- Testosterone
- Dihydrotestosterone
- Anabolic
- Improve physique and performance Performance-enhancing substance
- Controlled substance
- Potent Potency (pharmacology)
- Inhibitor Enzyme inhibitor
- 11β-hydroxysteroid dehydrogenase
- Type 2 Corticosteroid 11-beta-dehydrogenase isozyme 2
Medical uses
- Androgen deficiency Hypoandrogenism
- Tablets Tablet (pharmacy)
Non-medical uses
- Physique- and performance-enhancing purposes Performance-enhancing drug
- Competitive Competition
- Athletes Athlete
- Bodybuilders Bodybuilder
- Powerlifters Powerlifter
Side effects
Pharmacology
- Substrate Substrate (biochemistry)
- 5α- 5α-reductase
- Skin
- Hair follicles Hair follicle
- Prostate gland
- Metabolized Metabolism
- 5α-dihydrofluoxymesterone
- Aromatizable Aromatase
- Steric hindrance
- Estrogenic Estrogen (medication)
- Progestogenic Progestogen
- Bioavailability
- Methyl group
- First-pass metabolism
- Sex hormone-binding globulin
- Liver
- Hydroxylation
- 5β-reduction 5β-reductase
- 3α- 3α-hydroxysteroid dehydrogenase
- 3β-keto-oxidation 3β-hydroxysteroid dehydrogenase
- Active metabolites Active metabolite
- 11-oxofluoxymesterone
- Elimination half-life
- Eliminated Elimination (pharmacology)
- Urine
- Excreted Excretion
Chemistry
- Androstane
- Steroid
- 17α-alkylated 17α-alkylated anabolic steroid
- Derivative Chemical derivative
Society and culture
- Generic name Generic term
- INN International Nonproprietary Name
- USP United States Pharmacopeia
- BAN British Approved Name
- DCIT Denominazione Comune Italiana
- JAN Japanese Accepted Name
- DCF Dénomination Commune Française
- Controlled Substances Act
Advanced semantic analysis
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
How this topic connects Entity context
Quick relationship hints grouped by predicate. Useful for spotting recurring semantic connections around the current entity.See the strongest relationship patterns around the current topic before diving into the raw triples.
Fluoxymesterone
Top relations
Important terminology Word statistics
Frequent words and multi-word phrases across the lead, headings, infobox and body. Useful for terminology coverage.Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
Important terminology
testosterone anabolic effects use steroid androgen group like hydroxyl united states side medical halotestin drug androgenic aas others names breast
Entity relationships Subject–Predicate–Object triples
Extracted RDF-like relationships with confidence and source. The table includes structured facts and lower-confidence contextual relations.| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Fluoxymesterone | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Fluoxymesterone | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Fluoxymesterone | ATC code | G03BA01 (WHO) | 1.00 | infobox |
| Fluoxymesterone | Bioavailability | Oral: 80% | 1.00 | infobox |
| Fluoxymesterone | CAS Number | 76-43-7 Y | 1.00 | infobox |
| Fluoxymesterone | ChEBI | CHEBI:5120 Y | 1.00 | infobox |
| Fluoxymesterone | ChEMBL | ChEMBL1445 Y | 1.00 | infobox |
| Fluoxymesterone | ChemSpider | 6205 Y | 1.00 | infobox |
| Fluoxymesterone | CompTox Dashboard (EPA) | DTXSID8033512 | 1.00 | infobox |
| Fluoxymesterone | Drug class | Androgen; Anabolic steroid | 1.00 | infobox |
| Fluoxymesterone | DrugBank | DB01185 Y | 1.00 | infobox |
| Fluoxymesterone | ECHA InfoCard | 100.000.875 | 1.00 | infobox |
| Fluoxymesterone | Elimination half-life | 9.2 hours | 1.00 | infobox |
| Fluoxymesterone | Excretion | Urine (<5% unchanged) | 1.00 | infobox |
| Fluoxymesterone | Formula | C20H29FO3 | 1.00 | infobox |
| Fluoxymesterone | IUPHAR/BPS | 2861 | 1.00 | infobox |
| Fluoxymesterone | KEGG | D00327 Y | 1.00 | infobox |
| Fluoxymesterone | Legal status | BR: Class C5 (Anabolic steroids) | 1.00 | infobox |
| Fluoxymesterone | Legal status | CA: Schedule IV | 1.00 | infobox |
| Fluoxymesterone | Legal status | US: Schedule III | 1.00 | infobox |
| Fluoxymesterone | MedlinePlus | a682690 | 1.00 | infobox |
| Fluoxymesterone | Metabolism | Liver (6β-hydroxylation, 5α- and 5β-reduction, 3α- and 3β-keto-oxidation, 11β-hydroxy-oxidation) | 1.00 | infobox |
| Fluoxymesterone | Metabolites | • 5α-Dihydrofluoxymesterone • 11-Oxofluoxymesterone | 1.00 | infobox |
| Fluoxymesterone | Molar mass | 336.447 g·mol−1 | 1.00 | infobox |
| Fluoxymesterone | Other names | Fluoxymestrone; Androfluorene; NSC-12165; 9α-Fluoro-11β-hydroxy-17α-methyltestosterone; 9α-Fluoro-17α-methylandrost-4-en-11β,17β-diol-3-one | 1.00 | infobox |
| Fluoxymesterone | Pregnancy category | X | 1.00 | infobox |
| Fluoxymesterone | PubChem CID | 6446 | 1.00 | infobox |
| Fluoxymesterone | Routes of administration | By mouth | 1.00 | infobox |
| Fluoxymesterone | Trade names | Halotestin, Ora-Testryl, Ultandren, others | 1.00 | infobox |
| Fluoxymesterone | UNII | 9JU12S4YFY | 1.00 | infobox |
Related concept clusters Concept neighborhoods
Clusters of nearby vocabulary surrounding the topic. Scan them for adjacent concepts and language you may have missed.These clusters group vocabulary that occurs around closely connected concepts in the source material.
Connections between topic areas Semantic bridges
Bridge nodes connect otherwise separate parts of the map. Expand a row to inspect the topic groups on each side.Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.